(IRS) IRSA Inversiones Y - Overview
Sector: Real EstateIndustry: Real Estate Services | Exchange NYSE (USA) | Currency USD | Market Cap: 1.194m | Total Return 24.5% in 12m
Stock: Real Estate, Hotels, Development, Rental
Total Rating 50
Risk 40
Buy Signal -0.33
| Risk 5d forecast | |
|---|---|
| Volatility | 49.8% |
| Relative Tail Risk | -7.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.58 |
| Alpha | 11.62 |
| Character TTM | |
|---|---|
| Beta | 0.908 |
| Beta Downside | 0.442 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.01% |
| CAGR/Max DD | 1.67 |
EPS (Earnings per Share)
Revenue
Description: IRS IRSA Inversiones Y March 05, 2026
IRSA Inversiones y Representaciones (IRS) is an Argentine real estate company. It operates in multiple segments, including shopping malls, offices, sales and developments, hotels, and other ventures. Real estate development often involves long lead times from acquisition to revenue generation.
The company acquires, develops, and operates commercial properties for rental, including shopping malls and office buildings. Commercial real estate rental income is typically driven by occupancy rates and lease terms.
IRS also develops and sells residential properties and acquires land for future development or sale. The residential real estate market can be sensitive to economic cycles and interest rates.
Additionally, IRS owns and operates luxury hotels and provides services such as stadium development and a digital customer loyalty platform. Hotel operations are influenced by tourism and business travel trends.
To deepen your understanding of IRSs market position and financial health, consider exploring its detailed financials on ValueRay.
Headlines to watch out for
- Argentine inflation impacts real estate rental income
- Shopping mall occupancy rates drive revenue growth
- Residential property sales fluctuate with economic stability
- Hotel tourism recovery boosts hospitality segment
- Land development pipeline expands future revenue opportunities
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 461.76b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.48 > 1.0 |
| NWC/Revenue: 116.1% < 20% (prev -22.21%; Δ 138.4% < -1%) |
| CFO/TA 0.06 > 3% & CFO 265.74b > Net Income 461.76b |
| Net Debt (701.77b) to EBITDA (511.31b): 1.37 < 3 |
| Current Ratio: 5.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (84.5m) vs 12m ago 0.0% < -2% |
| Gross Margin: 34.77% > 18% (prev 0.62%; Δ 3.41k% > 0.5%) |
| Asset Turnover: 15.27% > 50% (prev 19.60%; Δ -4.33% > 0%) |
| Interest Coverage Ratio: 8.15 > 6 (EBITDA TTM 511.31b / Interest Expense TTM 61.76b) |
Altman Z'' 2.94
| A: 0.14 (Total Current Assets 711.19b - Total Current Liabilities 118.74b) / Total Assets 4179.16b |
| B: 0.14 (Retained Earnings 580.15b / Total Assets 4179.16b) |
| C: 0.15 (EBIT TTM 503.29b / Avg Total Assets 3340.48b) |
| D: 0.52 (Book Value of Equity 1142.06b / Total Liabilities 2215.78b) |
| Altman-Z'' Score: 2.94 = A |
Beneish M -1.29
| DSRI: 2.20 (Receivables 191.93b/83.74b, Revenue 510.08b/490.45b) |
| GMI: 1.79 (GM 34.77% / 62.06%) |
| AQI: 0.93 (AQ_t 0.81 / AQ_t-1 0.87) |
| SGI: 1.04 (Revenue 510.08b / 490.45b) |
| TATA: 0.05 (NI 461.76b - CFO 265.74b) / TA 4179.16b) |
| Beneish M-Score: -1.29 (Cap -4..+1) = D |
What is the price of IRS shares?
As of March 27, 2026, the stock is trading at USD 15.35 with a total of 247,193 shares traded.
Over the past week, the price has changed by +6.38%, over one month by -4.24%, over three months by -4.24% and over the past year by +24.53%.
Over the past week, the price has changed by +6.38%, over one month by -4.24%, over three months by -4.24% and over the past year by +24.53%.
Is IRS a buy, sell or hold?
IRSA Inversiones Y has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy IRS.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.3 | 39% |
| Analysts Target Price | 21.3 | 39% |
IRS Fundamental Data Overview March 25, 2026
P/E Trailing = 3.3759
P/E Forward = 38.1679
P/S = 0.0024
P/B = 0.8302
P/EG = 2.7255
Revenue TTM = 510.08b USD
EBIT TTM = 503.29b USD
EBITDA TTM = 511.31b USD
Long Term Debt = 872.13b USD (from longTermDebt, last quarter)
Short Term Debt = 118.74b USD (from shortTermDebt, last quarter)
Debt = 997.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 701.77b USD (from netDebt column, last quarter)
Enterprise Value = 702.97b USD (1.19b + Debt 997.91b - CCE 296.14b)
Interest Coverage Ratio = 8.15 (Ebit TTM 503.29b / Interest Expense TTM 61.76b)
EV/FCF = 2.72x (Enterprise Value 702.97b / FCF TTM 258.00b)
FCF Yield = 36.70% (FCF TTM 258.00b / Enterprise Value 702.97b)
FCF Margin = 50.58% (FCF TTM 258.00b / Revenue TTM 510.08b)
Net Margin = 90.53% (Net Income TTM 461.76b / Revenue TTM 510.08b)
Gross Margin = 34.77% ((Revenue TTM 510.08b - Cost of Revenue TTM 332.74b) / Revenue TTM)
Gross Margin QoQ = 62.93% (prev 61.39%)
Tobins Q-Ratio = 0.17 (Enterprise Value 702.97b / Total Assets 4179.16b)
Interest Expense / Debt = 2.12% (Interest Expense 21.13b / Debt 997.91b)
Taxrate = 11.38% (9.32b / 81.86b)
NOPAT = 446.00b (EBIT 503.29b * (1 - 11.38%))
Current Ratio = 5.99 (Total Current Assets 711.19b / Total Current Liabilities 118.74b)
Debt / Equity = 0.54 (Debt 997.91b / totalStockholderEquity, last quarter 1854.01b)
Debt / EBITDA = 1.37 (Net Debt 701.77b / EBITDA 511.31b)
Debt / FCF = 2.72 (Net Debt 701.77b / FCF TTM 258.00b)
Total Stockholder Equity = 1481.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.82% (Net Income 461.76b / Total Assets 4179.16b)
RoE = 31.18% (Net Income TTM 461.76b / Total Stockholder Equity 1481.03b)
RoCE = 21.39% (EBIT 503.29b / Capital Employed (Equity 1481.03b + L.T.Debt 872.13b))
RoIC = 18.07% (NOPAT 446.00b / Invested Capital 2468.86b)
WACC = 1.89% (E(1.19b)/V(999.11b) * Re(9.18%) + D(997.91b)/V(999.11b) * Rd(2.12%) * (1-Tc(0.11)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 6.35%
[DCF] Terminal Value 88.44% ; FCFF base≈211.73b ; Y1≈261.20b ; Y5≈445.65b
[DCF] Fair Price = 151k (EV 12928.42b - Net Debt 701.77b = Equity 12226.65b / Shares 81.1m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
[DCF] Fair Price = 151k (out of range, set to none)
EPS Correlation: 28.66 | EPS CAGR: 15.98% | SUE: 0.01 | # QB: 0
Revenue Correlation: 81.25 | Revenue CAGR: 130.8% | SUE: 0.58 | # QB: 0
EPS current Year (2026-06-30): EPS=0.13 | Chg7d=+0.060 | Chg30d=-0.008 | Revisions Net=+1 | Growth EPS=+6.8% | Growth Revenue=+9.8%
EPS next Year (2027-06-30): EPS=0.55 | Chg7d=-0.028 | Chg30d=+0.398 | Revisions Net=+1 | Growth EPS=+327.8% | Growth Revenue=+6.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -20.4% (Discount Rate 9.2% - Earnings Yield 29.6%)
[Growth] Growth Spread = +26.9% (Analyst 6.4% - Implied -20.4%)
P/E Forward = 38.1679
P/S = 0.0024
P/B = 0.8302
P/EG = 2.7255
Revenue TTM = 510.08b USD
EBIT TTM = 503.29b USD
EBITDA TTM = 511.31b USD
Long Term Debt = 872.13b USD (from longTermDebt, last quarter)
Short Term Debt = 118.74b USD (from shortTermDebt, last quarter)
Debt = 997.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 701.77b USD (from netDebt column, last quarter)
Enterprise Value = 702.97b USD (1.19b + Debt 997.91b - CCE 296.14b)
Interest Coverage Ratio = 8.15 (Ebit TTM 503.29b / Interest Expense TTM 61.76b)
EV/FCF = 2.72x (Enterprise Value 702.97b / FCF TTM 258.00b)
FCF Yield = 36.70% (FCF TTM 258.00b / Enterprise Value 702.97b)
FCF Margin = 50.58% (FCF TTM 258.00b / Revenue TTM 510.08b)
Net Margin = 90.53% (Net Income TTM 461.76b / Revenue TTM 510.08b)
Gross Margin = 34.77% ((Revenue TTM 510.08b - Cost of Revenue TTM 332.74b) / Revenue TTM)
Gross Margin QoQ = 62.93% (prev 61.39%)
Tobins Q-Ratio = 0.17 (Enterprise Value 702.97b / Total Assets 4179.16b)
Interest Expense / Debt = 2.12% (Interest Expense 21.13b / Debt 997.91b)
Taxrate = 11.38% (9.32b / 81.86b)
NOPAT = 446.00b (EBIT 503.29b * (1 - 11.38%))
Current Ratio = 5.99 (Total Current Assets 711.19b / Total Current Liabilities 118.74b)
Debt / Equity = 0.54 (Debt 997.91b / totalStockholderEquity, last quarter 1854.01b)
Debt / EBITDA = 1.37 (Net Debt 701.77b / EBITDA 511.31b)
Debt / FCF = 2.72 (Net Debt 701.77b / FCF TTM 258.00b)
Total Stockholder Equity = 1481.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.82% (Net Income 461.76b / Total Assets 4179.16b)
RoE = 31.18% (Net Income TTM 461.76b / Total Stockholder Equity 1481.03b)
RoCE = 21.39% (EBIT 503.29b / Capital Employed (Equity 1481.03b + L.T.Debt 872.13b))
RoIC = 18.07% (NOPAT 446.00b / Invested Capital 2468.86b)
WACC = 1.89% (E(1.19b)/V(999.11b) * Re(9.18%) + D(997.91b)/V(999.11b) * Rd(2.12%) * (1-Tc(0.11)))
Discount Rate = 9.18% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 6.35%
[DCF] Terminal Value 88.44% ; FCFF base≈211.73b ; Y1≈261.20b ; Y5≈445.65b
[DCF] Fair Price = 151k (EV 12928.42b - Net Debt 701.77b = Equity 12226.65b / Shares 81.1m; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
[DCF] Fair Price = 151k (out of range, set to none)
EPS Correlation: 28.66 | EPS CAGR: 15.98% | SUE: 0.01 | # QB: 0
Revenue Correlation: 81.25 | Revenue CAGR: 130.8% | SUE: 0.58 | # QB: 0
EPS current Year (2026-06-30): EPS=0.13 | Chg7d=+0.060 | Chg30d=-0.008 | Revisions Net=+1 | Growth EPS=+6.8% | Growth Revenue=+9.8%
EPS next Year (2027-06-30): EPS=0.55 | Chg7d=-0.028 | Chg30d=+0.398 | Revisions Net=+1 | Growth EPS=+327.8% | Growth Revenue=+6.4%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -20.4% (Discount Rate 9.2% - Earnings Yield 29.6%)
[Growth] Growth Spread = +26.9% (Analyst 6.4% - Implied -20.4%)